TTM
22.3%
YoY change
+0.66pp
Trough year (1999)
-2.4%
Peak year (2011)
42.6%
Latest annual
21.0%
FCF Margin history chart for Bio-Techne (TECH) from 1990 to 2025
Latest: 21.0%
FCF Margin change chart for Bio-Techne (TECH) from 1990 to 2025
Latest: +0.66pp
FCF Margin history table for Bio-Techne (TECH) from 1990 to 2025
| 2025 | 21.0% | +0.66pp | ||
| 2024 | 20.4% | +1.35pp | ||
| 2023 | 19.0% | -6.34pp | ||
| 2022 | 25.4% | -7.71pp | ||
| 2021 | 33.1% | +12.29pp | ||
| 2020 | 20.8% | -1.10pp | ||
| 2019 | 21.9% | -1.36pp | ||
| 2018 | 23.2% | +0.46pp | ||
| 2017 | 22.8% | -2.66pp | ||
| 2016 | 25.4% | -0.97pp | ||
| 2015 | 26.4% | -7.95pp | ||
| 2014 | 34.4% | +1.81pp | ||
| 2013 | 32.6% | -5.83pp | ||
| 2012 | 38.4% | -4.23pp | ||
| 2011 | 42.6% | +2.99pp | ||
| 2010 | 39.6% | -0.06pp | ||
| 2009 | 39.7% | +1.25pp | ||
| 2008 | 38.4% | +1.56pp | ||
| 2007 | 36.9% | -3.09pp | ||
| 2006 | 40.0% | +4.69pp | ||
| 2005 | 35.3% | -3.07pp | ||
| 2004 | 38.4% | +11.53pp | ||
| 2003 | 26.8% | +22.70pp | ||
| 2002 | 4.1% | -30.17pp | ||
| 2001 | 34.3% | +26.23pp | ||
| 2000 | 8.1% | +10.48pp | ||
| 1999 | -2.4% | -28.13pp | ||
| 1998 | 25.7% | +12.08pp | ||
| 1997 | 13.6% | +7.40pp | ||
| 1996 | 6.2% | -6.35pp | ||
| 1995 | 12.6% | +0.17pp | ||
| 1994 | 12.4% | +5.79pp | ||
| 1993 | 6.6% | -8.18pp | ||
| 1992 | 14.8% | +10.13pp | ||
| 1991 | 4.7% | +0.20pp | ||
| 1990 | 4.5% | — |
- 202521.0%+0.66pp
- 202420.4%+1.35pp
- 202319.0%-6.34pp
- 202225.4%-7.71pp
- 202133.1%+12.29pp
- 202020.8%-1.10pp
- 201921.9%-1.36pp
- 201823.2%+0.46pp
- 201722.8%-2.66pp
- 201625.4%-0.97pp
- 201526.4%-7.95pp
- 201434.4%+1.81pp
- 201332.6%-5.83pp
- 201238.4%-4.23pp
- 201142.6%+2.99pp
- 201039.6%-0.06pp
- 200939.7%+1.25pp
- 200838.4%+1.56pp
- 200736.9%-3.09pp
- 200640.0%+4.69pp
- 200535.3%-3.07pp
- 200438.4%+11.53pp
- 200326.8%+22.70pp
- 20024.1%-30.17pp
- 200134.3%+26.23pp
- 20008.1%+10.48pp
- 1999-2.4%-28.13pp
- 199825.7%+12.08pp
- 199713.6%+7.40pp
- 19966.2%-6.35pp
- 199512.6%+0.17pp
- 199412.4%+5.79pp
- 19936.6%-8.18pp
- 199214.8%+10.13pp
- 19914.7%+0.20pp
- 19904.5%—
FCF Margin values are taken from Bio-Techne's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About FCF Margin at Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's latest reported free cash flow margin is 22.3%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual free cash flow margin for Bio-Techne (TECH) came in at 21.03% – expanded 0.7 percentage points year-over-year.
Across the available history, free cash flow margin reached its high of 42.61% in 2011 and its low of -2.42% in 1999.
Bio-Techne FCF Margin by Year
Bio-Techne FCF Margin 2025: 21.0%
In 2025, Bio-Techne reported free cash flow margin of 21.03%, expanded 0.7 percentage points from 2024.
Bio-Techne FCF Margin 2024: 20.4%
Bio-Techne free cash flow margin in 2024 was 20.37%, expanded 1.4 percentage points from 2023.
Bio-Techne FCF Margin 2023: 19.0%
2023's free cash flow margin for Bio-Techne came in at 19.02%, contracted 6.3 percentage points from 2022.
Bio-Techne FCF Margin 2022: 25.4%
Bio-Techne posted free cash flow margin of 25.36% in 2022, contracted 7.7 percentage points from 2021.
Bio-Techne FCF Margin 2021: 33.1%
Bio-Techne free cash flow margin in 2021 was 33.07%.
See more financial history for Bio-Techne (TECH).
Sector peers by FCF Margin
Healthcare peers of Bio-Techne (TECH), ranked by their latest free cash flow margin
| 33.2% | |
| 23.1% | |
| 21.5% | |
| 18.8% | |
| 18.4% | |
| 15.1% | |
| 9.4% | |
| 4.4% |
- 33.2%
- 23.1%
- 21.5%
- 18.8%
- 15.1%
Frequently asked questions
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation